241 related articles for article (PubMed ID: 8002685)
1. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.
Psaty BM; Heckbert SR; Atkins D; Lemaitre R; Koepsell TD; Wahl PW; Siscovick DS; Wagner EH
Arch Intern Med; 1994 Jun; 154(12):1333-9. PubMed ID: 8002685
[TBL] [Abstract][Full Text] [Related]
2. Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women.
Heckbert SR; Weiss NS; Koepsell TD; Lemaitre RN; Smith NL; Siscovick DS; Lin D; Psaty BM
Arch Intern Med; 1997 Jun; 157(12):1330-6. PubMed ID: 9201007
[TBL] [Abstract][Full Text] [Related]
3. Leisure-time physical activity and the risk of nonfatal myocardial infarction in postmenopausal women.
Lemaitre RN; Heckbert SR; Psaty BM; Siscovick DS
Arch Intern Med; 1995 Nov; 155(21):2302-8. PubMed ID: 7487254
[TBL] [Abstract][Full Text] [Related]
4. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
[TBL] [Abstract][Full Text] [Related]
5. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
6. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.
Grodstein F; Stampfer MJ; Manson JE; Colditz GA; Willett WC; Rosner B; Speizer FE; Hennekens CH
N Engl J Med; 1996 Aug; 335(7):453-61. PubMed ID: 8672166
[TBL] [Abstract][Full Text] [Related]
7. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.
Hsia J; Langer RD; Manson JE; Kuller L; Johnson KC; Hendrix SL; Pettinger M; Heckbert SR; Greep N; Crawford S; Eaton CB; Kostis JB; Caralis P; Prentice R;
Arch Intern Med; 2006 Feb; 166(3):357-65. PubMed ID: 16476878
[TBL] [Abstract][Full Text] [Related]
8. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study.
Tetsche MS; Jacobsen J; Nørgaard M; Baron JA; Sørensen HT
Am J Gastroenterol; 2007 Feb; 102(2):275-8. PubMed ID: 17311649
[TBL] [Abstract][Full Text] [Related]
9. Common genetic variation in the prothrombin gene, hormone therapy, and incident nonfatal myocardial infarction in postmenopausal women.
Hindorff LA; Psaty BM; Carlson CS; Heckbert SR; Lumley T; Smith NL; Lemaitre RN; Rieder MJ; Nickerson DA; Reiner AP
Am J Epidemiol; 2006 Apr; 163(7):600-7. PubMed ID: 16467413
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.
Stampfer MJ; Colditz GA; Willett WC; Manson JE; Rosner B; Speizer FE; Hennekens CH
N Engl J Med; 1991 Sep; 325(11):756-62. PubMed ID: 1870648
[TBL] [Abstract][Full Text] [Related]
11. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal hormone therapy and mortality.
Grodstein F; Stampfer MJ; Colditz GA; Willett WC; Manson JE; Joffe M; Rosner B; Fuchs C; Hankinson SE; Hunter DJ; Hennekens CH; Speizer FE
N Engl J Med; 1997 Jun; 336(25):1769-75. PubMed ID: 9187066
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
14. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
15. Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women.
Rossi R; Bursi F; Veronesi B; Cagnacci A; Modena MG
Maturitas; 2004 Dec; 49(4):315-20. PubMed ID: 15531127
[TBL] [Abstract][Full Text] [Related]
16. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
[TBL] [Abstract][Full Text] [Related]
17. Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women.
Duvernoy CS; Rattenhuber J; Seifert-Klauss V; Bengel F; Meyer C; Schwaiger M
J Gend Specif Med; 2001; 4(3):21-7, 47. PubMed ID: 11605352
[TBL] [Abstract][Full Text] [Related]
18. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.
Psaty BM; Heckbert SR; Atkins D; Siscovick DS; Koepsell TD; Wahl PW; Longstreth WT; Weiss NS; Wagner EH; Prentice R
Arch Intern Med; 1993 Jun; 153(12):1421-7. PubMed ID: 8512434
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and risk of nonfatal acute myocardial infarction in Italy.
Tavani A; Bertuzzi M; Gallus S; Negri E; La Vecchia C
J Clin Epidemiol; 2005 Jul; 58(7):747-50. PubMed ID: 15939229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]